RAP 0.00% 20.5¢ resapp health limited

I’m not expecting too much in the quarterly for revenue. Cold...

  1. 168 Posts.
    lightbulb Created with Sketch. 56
    I’m not expecting too much in the quarterly for revenue. Cold and flu numbers as I understand are well down on an average year due to COVId hibernation.

    At least the quarterly will paint a relative picture of potential revenue from ResAppDx pending further uptake.

    Android compatibility key with the current delivery model. Otherwise it could be back to the drawing board for a while for that part of the business development.

    I find it frustrating that we haven’t had an update on Android yet given previous statements and sentiment. A progress report would be good wow just an update please!

    Europe... well what’s happening there?

    Lots going on, many potential great announcements to come.

    Hang on to your hats it gonna be a wild ride either way!
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.